| Binson's Home Health Care Center's | |
| 6475 Rochester Road, Troy, Michigan 48085 | |
| (248) 828-8400 |
| Name | Binson's Home Health Care Center's |
|---|---|
| Organization Name | Binson's Hospital Supplies, Inc. |
| Location | 6475 Rochester Road, Troy, Michigan 48085 |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Phone | (248) 828-8400 |
| Participate in Medicare | Medicare enrolled and may accept medicare assignment. Please check with the supplier if they accept medicare-approved amount before you get your prescription drugs, equipment or supplies from this supplier. |
News Archive
Resverlogix Corp. ("Resverlogix" or the "Company") announced today that it has begun dosing patients in its US Phase 2 clinical trial lead by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with stable coronary artery disease (CAD).
Nuvilex, Inc., an emerging biotechnology provider of cell and gene therapy solutions, today provided additional details based on the Goldman Small Cap Research report issued February 29, 2012, that highlighted the company's cell encapsulation technology and its benefits for treating chronic diseases such as diabetes.
Nearly 100 years after a British neurologist first mapped the blind spots caused by missile wounds to the brains of soldiers, Perelman School of Medicine researchers at the University of Pennsylvania have perfected his map using modern-day technology. Their results create a map of vision in the brain based upon an individual's brain structure, even for people who cannot see.
The Prem Rawat Foundation (TPRF) recently became an active partner in the battle against a cholera epidemic in Haiti that has reportedly infected an estimated 600,000 people and left more than 2,400 dead.
Barr Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted for review Duramed Pharmaceuticals, Inc.'s Adenovirus Types 4 and 7 Live Oral Vaccines Biologics License Application (BLA).
› Verified 2 days ago
| NPI Number | 1407915689 |
| Organization Name | BINSON'S HOSPITAL SUPPLIES, INC. |
| Doing Business As | BINSON'S HOME HEALTH CARE SERVICES |
| Type | Durable Medical Equipment & Medical Supplies Supplier |
| Address | 6475 Rochester Rd, Troy, MI 48085 |
| Phone Number | 248-828-8400 |
News Archive
Resverlogix Corp. ("Resverlogix" or the "Company") announced today that it has begun dosing patients in its US Phase 2 clinical trial lead by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with stable coronary artery disease (CAD).
Nuvilex, Inc., an emerging biotechnology provider of cell and gene therapy solutions, today provided additional details based on the Goldman Small Cap Research report issued February 29, 2012, that highlighted the company's cell encapsulation technology and its benefits for treating chronic diseases such as diabetes.
Nearly 100 years after a British neurologist first mapped the blind spots caused by missile wounds to the brains of soldiers, Perelman School of Medicine researchers at the University of Pennsylvania have perfected his map using modern-day technology. Their results create a map of vision in the brain based upon an individual's brain structure, even for people who cannot see.
The Prem Rawat Foundation (TPRF) recently became an active partner in the battle against a cholera epidemic in Haiti that has reportedly infected an estimated 600,000 people and left more than 2,400 dead.
Barr Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted for review Duramed Pharmaceuticals, Inc.'s Adenovirus Types 4 and 7 Live Oral Vaccines Biologics License Application (BLA).
› Verified 2 days ago
| NPI Number | 1710036827 |
| Organization Name | BINSON'S HOSPITAL SUPPLIES, INC. |
| Doing Business As | BINSON'S HOME HEALTH CARE SERVICES |
| Type | Prosthetic/Orthotic Supplier |
| Address | 6475 Rochester Rd, Troy, MI 48085 |
| Phone Number | 248-828-8400 |
News Archive
Resverlogix Corp. ("Resverlogix" or the "Company") announced today that it has begun dosing patients in its US Phase 2 clinical trial lead by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with stable coronary artery disease (CAD).
Nuvilex, Inc., an emerging biotechnology provider of cell and gene therapy solutions, today provided additional details based on the Goldman Small Cap Research report issued February 29, 2012, that highlighted the company's cell encapsulation technology and its benefits for treating chronic diseases such as diabetes.
Nearly 100 years after a British neurologist first mapped the blind spots caused by missile wounds to the brains of soldiers, Perelman School of Medicine researchers at the University of Pennsylvania have perfected his map using modern-day technology. Their results create a map of vision in the brain based upon an individual's brain structure, even for people who cannot see.
The Prem Rawat Foundation (TPRF) recently became an active partner in the battle against a cholera epidemic in Haiti that has reportedly infected an estimated 600,000 people and left more than 2,400 dead.
Barr Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted for review Duramed Pharmaceuticals, Inc.'s Adenovirus Types 4 and 7 Live Oral Vaccines Biologics License Application (BLA).
› Verified 2 days ago
News Archive
Resverlogix Corp. ("Resverlogix" or the "Company") announced today that it has begun dosing patients in its US Phase 2 clinical trial lead by Cleveland Clinic. This trial will examine RVX-208, Resverlogix's oral small molecule therapy for the treatment of atherosclerosis, in patients with stable coronary artery disease (CAD).
Nuvilex, Inc., an emerging biotechnology provider of cell and gene therapy solutions, today provided additional details based on the Goldman Small Cap Research report issued February 29, 2012, that highlighted the company's cell encapsulation technology and its benefits for treating chronic diseases such as diabetes.
Nearly 100 years after a British neurologist first mapped the blind spots caused by missile wounds to the brains of soldiers, Perelman School of Medicine researchers at the University of Pennsylvania have perfected his map using modern-day technology. Their results create a map of vision in the brain based upon an individual's brain structure, even for people who cannot see.
The Prem Rawat Foundation (TPRF) recently became an active partner in the battle against a cholera epidemic in Haiti that has reportedly infected an estimated 600,000 people and left more than 2,400 dead.
Barr Pharmaceuticals, Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted for review Duramed Pharmaceuticals, Inc.'s Adenovirus Types 4 and 7 Live Oral Vaccines Biologics License Application (BLA).
› Verified 2 days ago
Binson's Home Health Care Center's Type: Durable Medical Equipment & Medical Supplies Supplier Location: 6475 Rochester Road, Troy, Michigan 48085 Phone: (248) 828-8400 | |
Rite Aid Pharmacy 04305 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 2971 W Maple Rd, Troy, Michigan 48084 Phone: (248) 288-4385 | |
Cvs Pharmacy #16656 Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1301 Coolidge Hwy, Troy, Michigan 48084 Phone: (248) 614-2801 | |
Sun Medical Equipment Company Type: Durable Medical Equipment & Medical Supplies Supplier Location: 1938 Woodslee Dr, Troy, Michigan 48083 Phone: (248) 280-2020 | |
Medsupply Corporation Inc Type: Durable Medical Equipment & Medical Supplies Supplier Location: 33333 Dequindre Rd, Troy, Michigan 48083 Phone: (248) 597-9004 |